These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 14745033

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses.
    Tan JT, Whitmire JK, Ahmed R, Pearson TC, Larsen CP.
    J Immunol; 1999 Nov 01; 163(9):4859-68. PubMed ID: 10528187
    [Abstract] [Full Text] [Related]

  • 5. Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes.
    Grünebach F, Kayser K, Weck MM, Müller MR, Appel S, Brossart P.
    Cancer Gene Ther; 2005 Sep 01; 12(9):749-56. PubMed ID: 15877082
    [Abstract] [Full Text] [Related]

  • 6. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.
    Lu ZY, Condomines M, Tarte K, Nadal L, Delteil MC, Rossi JF, Ferrand C, Klein B.
    Exp Hematol; 2007 Mar 01; 35(3):443-53. PubMed ID: 17309825
    [Abstract] [Full Text] [Related]

  • 7. Preferential T cell expansion by artificial antigen presenting cells expressing 4-1BBL alone or in combination with CD80 or CD86.
    Habib-Agahi M, Jaberipour M, Phan TT, Searle PF.
    Iran J Immunol; 2008 Sep 01; 5(3):136-47. PubMed ID: 18791280
    [Abstract] [Full Text] [Related]

  • 8. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
    Du X, Zheng G, Jin H, Kang Y, Wang J, Xiao C, Zhang S, Zhao L, Chen A, Wang B.
    J Gene Med; 2007 Feb 01; 9(2):136-46. PubMed ID: 17310492
    [Abstract] [Full Text] [Related]

  • 9. 4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.
    Harrison JM, Bertram EM, Boyle DB, Coupar BE, Ranasinghe C, Ramshaw IA.
    Vaccine; 2006 Nov 17; 24(47-48):6867-74. PubMed ID: 17050052
    [Abstract] [Full Text] [Related]

  • 10. 4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors.
    Guinn BA, Bertram EM, DeBenedette MA, Berinstein NL, Watts TH.
    Cell Immunol; 2001 May 25; 210(1):56-65. PubMed ID: 11485353
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand.
    Gramaglia I, Cooper D, Miner KT, Kwon BS, Croft M.
    Eur J Immunol; 2000 Feb 25; 30(2):392-402. PubMed ID: 10671194
    [Abstract] [Full Text] [Related]

  • 17. Induction of T-cell immunity against Epstein-Barr virus-associated tumors by means of adenovirally transduced dendritic cells.
    Sun H, Yao K, Chen Y, Zhou F.
    Chin Med J (Engl); 2004 Oct 25; 117(10):1558-63. PubMed ID: 15498383
    [Abstract] [Full Text] [Related]

  • 18. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    Wen T, Bukczynski J, Watts TH.
    J Immunol; 2002 May 15; 168(10):4897-906. PubMed ID: 11994439
    [Abstract] [Full Text] [Related]

  • 19. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K, Neena K, Chitralekha KT, Arif AK, Tomar D, Rao DN.
    Int Immunopharmacol; 2004 Jan 15; 4(1):1-14. PubMed ID: 14975355
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.